Dorchester Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-90,705
| Closed | -$3.01M | – | 113 |
|
2017
Q2 | $3.01M | Sell |
90,705
-515
| -0.6% | -$17.1K | 1.04% | 32 |
|
2017
Q1 | $2.93M | Buy |
91,220
+10,680
| +13% | +$343K | 1.02% | 31 |
|
2016
Q4 | $2.92M | Buy |
80,540
+10,870
| +16% | +$394K | 1.06% | 32 |
|
2016
Q3 | $3.21M | Buy |
69,670
+1,920
| +3% | +$88.4K | 1.19% | 29 |
|
2016
Q2 | $3.4M | Buy |
67,750
+11,045
| +19% | +$555K | 1.26% | 28 |
|
2016
Q1 | $3.03M | Buy |
56,705
+1,555
| +3% | +$83.2K | 1.15% | 33 |
|
2015
Q4 | $3.62M | Buy |
55,150
+455
| +0.8% | +$29.9K | 1.5% | 25 |
|
2015
Q3 | $4.12M | Sell |
54,695
-490
| -0.9% | -$36.9K | 1.52% | 27 |
|
2015
Q2 | $4.07M | Buy |
+55,185
| New | +$4.07M | 1.34% | 26 |
|